|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03737 ZHONGZHIPHARM
Nominal 
0.710 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 789,963 | -10.280% | 1,737,487 | 2,214,783 | 2,049,812 | 1,825,935 |
| Cost of Sales | (371,775) | -6.580% | (791,599) | (926,376) | (831,669) | (753,640) |
| Gross Profit | 418,188 | -13.332% | 945,888 | 1,288,407 | 1,218,143 | 1,072,295 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 4 | -- | (760) | (4,100) | (474) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 13,534 | 2155.667% | 18,987 | 146,897 | 207,581 | 130,651 | |
| Taxation | (4,469) | -- | (1,285) | (50,750) | (43,447) | (23,736) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 51 | -- | (412) | (935) | (1,359) | (528) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 9,116 | 3.791% | 17,290 | 95,212 | 162,775 | 106,387 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,144 | 50.526% | 2,388 | 1,855 | 883 | 2,667 |
| Depreciation & Amortisation | 46,434 | -2.050% | 102,481 | 111,421 | 102,079 | 96,384 |
| Directors' Emoluments | -- | -- | 9,086 | 10,668 | 6,586 | 6,090 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified (Modified Report) |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.100 | 10.000% | 2.000 | 11.000 | 19.000 | 13.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 4.615 | 8.170 | 7.880 |
| Dividend Payout Ratio (%) | -- | -- | -- | 41.952% | 43.000% | 60.612% |
| Cash flow per share ($) | -- | -- | 0.218 | 0.215 | 0.120 | 0.336 |
| NBV per share ($) | 1.276 | -- | 1.268 | 1.293 | 1.214 | 1.161 |
| Remarks: | Real time quote last updated: 10/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 9,116 |
| %Change | 3.791% |
| EPS / (LPS) | RMB 0.011 |
| NBV Per Share (¥) | RMB 1.276 |